ShareHope Medicine Co., Ltd. (TPEX:8403)
Taiwan · Delayed Price · Currency is TWD 19.70
+0.10 (0.51%)
Jun 3, 2026, 1:30 PM CST
ShareHope Medicine Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,698 | 3,214 | 3,795 | 4,147 | 4,057 | 3,087 | |
Market Cap Growth | -27.79% | -15.31% | -8.49% | 2.20% | 31.44% | -18.51% |
Enterprise Value | 3,352 | 3,785 | 4,818 | 5,404 | 5,292 | 3,547 |
Last Close Price | 19.60 | 23.35 | 27.07 | 29.21 | 28.17 | 21.15 |
PE Ratio | 21.07 | 22.68 | 18.97 | 33.29 | 13.80 | 13.27 |
Forward PE | - | 17.88 | 17.88 | 17.88 | 17.88 | 17.88 |
PS Ratio | 0.62 | 0.74 | 0.88 | 1.07 | 0.98 | 0.80 |
PB Ratio | 0.71 | 0.84 | 0.95 | 1.05 | 0.99 | 0.80 |
P/TBV Ratio | 0.87 | 1.03 | 1.17 | 1.32 | 1.32 | 1.10 |
P/FCF Ratio | 8.44 | 13.38 | 20.67 | 607.42 | - | 13.87 |
P/OCF Ratio | 6.29 | 8.83 | 14.23 | 16.13 | 6.32 | 8.57 |
EV/Sales Ratio | 0.76 | 0.87 | 1.11 | 1.40 | 1.28 | 0.92 |
EV/EBITDA Ratio | 8.50 | 10.66 | 17.92 | 19.57 | 10.59 | 8.15 |
EV/EBIT Ratio | 23.05 | 23.87 | 113.07 | 57.07 | 16.07 | 13.95 |
EV/FCF Ratio | 10.48 | 15.76 | 26.24 | 791.50 | - | 15.94 |
Debt / Equity Ratio | 0.47 | 0.47 | 0.50 | 0.55 | 0.49 | 0.31 |
Debt / EBITDA Ratio | 4.48 | 4.31 | 5.90 | 5.41 | 3.19 | 2.19 |
Debt / FCF Ratio | 5.56 | 7.46 | 10.82 | 319.32 | - | 5.43 |
Net Debt / Equity Ratio | 0.07 | 0.06 | 0.13 | 0.20 | 0.11 | -0.09 |
Net Debt / EBITDA Ratio | 0.81 | 0.66 | 1.92 | 2.85 | 0.92 | -0.82 |
Net Debt / FCF Ratio | 0.86 | 0.98 | 2.82 | 115.21 | -0.74 | -1.61 |
Asset Turnover | 0.66 | 0.64 | 0.60 | 0.52 | 0.61 | 0.65 |
Inventory Turnover | 12.75 | 12.49 | 12.27 | 11.06 | 11.20 | 9.69 |
Quick Ratio | 1.79 | 1.78 | 1.63 | 1.45 | 1.66 | 1.91 |
Current Ratio | 2.02 | 2.00 | 1.82 | 1.65 | 1.85 | 2.14 |
Return on Equity (ROE) | 2.67% | 2.86% | 3.08% | 1.37% | 6.12% | 5.18% |
Return on Assets (ROA) | 1.38% | 1.44% | 0.37% | 0.80% | 3.05% | 2.69% |
Return on Invested Capital (ROIC) | 2.72% | 2.76% | 0.65% | 1.03% | 5.85% | 5.78% |
Return on Capital Employed (ROCE) | 2.90% | 3.10% | 0.80% | 1.70% | 5.80% | 5.50% |
Earnings Yield | 4.76% | 4.41% | 5.27% | 3.00% | 7.25% | 7.54% |
FCF Yield | 11.85% | 7.47% | 4.84% | 0.17% | -15.37% | 7.21% |
Dividend Yield | 2.43% | - | 1.85% | 1.25% | 1.55% | 1.96% |
Payout Ratio | 50.99% | 46.25% | 25.20% | 48.19% | 19.45% | 44.19% |
Buyback Yield / Dilution | 0.07% | 0.02% | -0.03% | 0.26% | 0.28% | 1.83% |
Total Shareholder Return | 2.50% | 0.02% | 1.82% | 1.51% | 1.83% | 3.80% |